About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Hnf1a
HNF1 homeobox A
MGI:98504
63 phenotypes from 4 alleles in 3 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
involves: 129X1/SvJ * C57BL/6J 		abnormal hepatocyte morphology J:47008
abnormal pancreatic islet morphology J:47008
abnormal reproductive system morphology J:47008
abnormal sexual interaction J:47008
abnormal spermatogenesis J:47008
decreased body size J:47008
decreased circulating insulin level J:47008
decreased circulating insulin-like growth factor I level J:47008
decreased pancreatic beta cell number J:47008
enlarged liver J:47008
hyperglycemia J:47008
increased cholesterol level J:47008
increased circulating growth hormone level J:47008
increased urine glucose level J:47008
infertility J:47008
polyuria J:47008
prenatal lethality, incomplete penetrance J:47008
Hnf1atm1.1Ylee/Hnf1atm2Ylee
involves: 129X1/SvJ * C57BL/6J 		abnormal liver morphology J:81639
decreased body size J:81639
decreased circulating insulin level J:81639
enlarged liver J:81639
hepatic steatosis J:81639
hyperglycemia J:81639
infertility J:81639
Hnf1atm1.1Ylee/Hnf1atm2Ylee
Speer6-ps1Tg(Alb-cre)21Mgn/?
involves: 129X1/SvJ * C57BL/6 * DBA 		decreased circulating insulin level J:81639
normal growth/size/body region phenotype J:81639
normal homeostasis/metabolism phenotype J:81639
hyperglycemia J:81639
normal reproductive system phenotype J:81639
Hnf1atm1Mya/Hnf1atm1Mya
involves: 129S2/SvPas 		abnormal circulating amino acid level J:31627
abnormal energy homeostasis J:31627
abnormal renal glucose reabsorption J:31627
abnormal stomach glandular epithelium morphology J:31627
abnormal urine calcium level J:31627
abnormal urine homeostasis J:31627
absent subcutaneous adipose tissue J:31627
aminoaciduria J:31627
argininuria J:31627
cachexia J:31627
decreased blood uric acid level J:31627
decreased body weight J:31627, J:48230
decreased bone mineral density J:31627
decreased circulating arginine level J:31627
decreased circulating lysine level J:31627
decreased creatinine clearance J:31627
decreased insulin secretion J:48230
decreased liver function J:31627
decreased pancreas weight J:48230
decreased pancreatic beta cell mass J:48230
decreased renal glomerular filtration rate J:31627
enlarged liver J:31627
hepatic steatosis J:31627
hydroxyprolinuria J:31627
increased circulating alanine transaminase level J:31627
increased circulating ammonia level J:31627
increased circulating aspartate transaminase level J:31627
increased circulating bilirubin level J:31627
increased circulating cholesterol level J:31627
increased circulating glucose level J:48230
increased circulating hydroxyproline level J:31627
increased circulating phenylalanine level J:31627
increased hepatocyte proliferation J:31627
increased liver weight J:31627
increased urine glucose level J:31627
increased urine phosphate level J:31627
increased urine uric acid level J:31627
jaundice J:31627
muscular atrophy J:31627
oroticaciduria J:31627
polyphagia J:31627
polyuria J:31627
postnatal growth retardation J:31627
premature death J:31627
prenatal lethality, incomplete penetrance J:31627
small pancreatic islets J:48230
Hnf1atm2Mya/Hnf1atm2Mya
involves: 129S2/SvPas 		abnormal circulating amino acid level J:31627
abnormal energy homeostasis J:31627
abnormal renal glucose reabsorption J:31627
abnormal stomach glandular epithelium morphology J:31627
abnormal urine calcium level J:31627
abnormal urine homeostasis J:31627
absent subcutaneous adipose tissue J:31627
aminoaciduria J:31627
argininuria J:31627
cachexia J:31627
decreased blood uric acid level J:31627
decreased body weight J:31627
decreased bone mineral density J:31627
decreased circulating arginine level J:31627
decreased circulating lysine level J:31627
decreased creatinine clearance J:31627
decreased liver function J:31627
decreased renal glomerular filtration rate J:31627
enlarged liver J:31627
hepatic steatosis J:31627
hydroxyprolinuria J:31627
increased circulating alanine transaminase level J:31627
increased circulating ammonia level J:31627
increased circulating aspartate transaminase level J:31627
increased circulating bilirubin level J:31627
increased circulating cholesterol level J:31627
increased circulating hydroxyproline level J:31627
increased circulating phenylalanine level J:31627
increased hepatocyte proliferation J:31627
increased liver weight J:31627
increased urine glucose level J:31627
increased urine phosphate level J:31627
increased urine uric acid level J:31627
jaundice J:31627
muscular atrophy J:31627
oroticaciduria J:31627
polyphagia J:31627
polyuria J:31627
postnatal growth retardation J:31627
premature death J:31627
prenatal lethality, incomplete penetrance J:31627
Hnf1atm2Ylee/Hnf1atm2Ylee
involves: 129X1/SvJ * C57BL/6J 		infertility J:81639
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory